197 related articles for article (PubMed ID: 7913500)
21. R(+)-8-OH-DPAT, a serotonin(1A) receptor agonist, potentiated S(-)-sulpiride-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens but not striatum.
Ichikawa J; Meltzer HY
J Pharmacol Exp Ther; 1999 Dec; 291(3):1227-32. PubMed ID: 10565846
[TBL] [Abstract][Full Text] [Related]
22. Induction of neurotensin and c-fos mRNA in distinct subregions of rat neostriatum after acute methamphetamine: comparison with acute haloperidol effects.
Merchant KM; Hanson GR; Dorsa DM
J Pharmacol Exp Ther; 1994 May; 269(2):806-12. PubMed ID: 8182549
[TBL] [Abstract][Full Text] [Related]
23. Long-term changes in basal ganglia function after a neurotoxic regimen of methamphetamine.
Chapman DE; Hanson GR; Kesner RP; Keefe KA
J Pharmacol Exp Ther; 2001 Feb; 296(2):520-7. PubMed ID: 11160639
[TBL] [Abstract][Full Text] [Related]
24. Response of extrapyramidal and limbic neuropeptides to fenfluramine administration: comparison with methamphetamine.
Hanson GR; Singh N; Bush L; Gibb JW
J Pharmacol Exp Ther; 1991 Dec; 259(3):1197-202. PubMed ID: 1722253
[TBL] [Abstract][Full Text] [Related]
25. Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice.
Ago Y; Nakamura S; Uda M; Kajii Y; Abe M; Baba A; Matsuda T
Neuropharmacology; 2006 Sep; 51(4):914-22. PubMed ID: 16863654
[TBL] [Abstract][Full Text] [Related]
26. Effects of a single dose of methamphetamine and iprindole on the serotonergic and dopaminergic system of the rat brain.
Peat MA; Warren PF; Gibb JW
J Pharmacol Exp Ther; 1983 Apr; 225(1):126-31. PubMed ID: 6187915
[TBL] [Abstract][Full Text] [Related]
27. Prenatal methamphetamine attenuates serotonin mediated renin secretion in male and female rat progeny: evidence for selective long-term dysfunction of serotonin pathways in brain.
Cabrera TM; Levy AD; Li Q; van de Kar LD; Battaglia G
Synapse; 1993 Nov; 15(3):198-208. PubMed ID: 8278897
[TBL] [Abstract][Full Text] [Related]
28. Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study.
Di Giovanni G; Di Matteo V; Di Mascio M; Esposito E
Synapse; 2000 Jan; 35(1):53-61. PubMed ID: 10579808
[TBL] [Abstract][Full Text] [Related]
29. 5-HT2 receptor blockade by ICI 169,369 and other 5-HT2 antagonists modulates the effects of D-2 dopamine receptor blockade.
Saller CF; Czupryna MJ; Salama AI
J Pharmacol Exp Ther; 1990 Jun; 253(3):1162-70. PubMed ID: 2141636
[TBL] [Abstract][Full Text] [Related]
30. Role of dopamine in the neurotoxic effects of methamphetamine.
Schmidt CJ; Ritter JK; Sonsalla PK; Hanson GR; Gibb JW
J Pharmacol Exp Ther; 1985 Jun; 233(3):539-44. PubMed ID: 2409267
[TBL] [Abstract][Full Text] [Related]
31. Microdialysis assessment of methamphetamine-induced changes in extracellular neurotensin in the striatum and nucleus accumbens.
Wagstaff JD; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1996 Aug; 278(2):547-54. PubMed ID: 8768703
[TBL] [Abstract][Full Text] [Related]
32. Methamphetamine, morphine, and their combination: acute changes in striatal dopaminergic transmission evaluated by microdialysis in awake rats.
Pereira FC; Lourenço E; Milhazes N; Morgadinho T; Ribeiro CF; Ali SF; Macedo TR
Ann N Y Acad Sci; 2006 Aug; 1074():160-73. PubMed ID: 17105914
[TBL] [Abstract][Full Text] [Related]
33. Further studies of the role of hyperthermia in methamphetamine neurotoxicity.
Bowyer JF; Davies DL; Schmued L; Broening HW; Newport GD; Slikker W; Holson RR
J Pharmacol Exp Ther; 1994 Mar; 268(3):1571-80. PubMed ID: 8138969
[TBL] [Abstract][Full Text] [Related]
34. The effects of chronic administration of quetiapine on the methamphetamine-induced recognition memory impairment and dopaminergic terminal deficit in rats.
He J; Yang Y; Yu Y; Li X; Li XM
Behav Brain Res; 2006 Sep; 172(1):39-45. PubMed ID: 16712969
[TBL] [Abstract][Full Text] [Related]
35. Differential response of neurotensin to methamphetamine self-administration.
Frankel PS; Hoonakker AJ; Hanson GR
Ann N Y Acad Sci; 2008 Oct; 1139():112-7. PubMed ID: 18991855
[TBL] [Abstract][Full Text] [Related]
36. Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents.
Albers DS; Sonsalla PK
J Pharmacol Exp Ther; 1995 Dec; 275(3):1104-14. PubMed ID: 8531070
[TBL] [Abstract][Full Text] [Related]
37. The influence of 5-HT2 and 5-HT4 receptor antagonists to modify drug induced disinhibitory effects in the mouse light/dark test.
Costall B; Naylor RJ
Br J Pharmacol; 1997 Nov; 122(6):1105-18. PubMed ID: 9401775
[TBL] [Abstract][Full Text] [Related]
38. Partial inhibition of reverse tolerance by a high dose of ritanserin or low dose of haloperidol in methamphetamine-sensitized rat.
Tanaka T; Ishigooka J; Watanabe S; Nagata E; Miura S
Nihon Shinkei Seishin Yakurigaku Zasshi; 1998 Feb; 18(1):1-7. PubMed ID: 9592805
[TBL] [Abstract][Full Text] [Related]
39. Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphetamine, two metabolites of 3,4-methylenedioxymethamphetamine, on central serotonergic and dopaminergic systems.
Johnson M; Elayan I; Hanson GR; Foltz RL; Gibb JW; Lim HK
J Pharmacol Exp Ther; 1992 May; 261(2):447-53. PubMed ID: 1349640
[TBL] [Abstract][Full Text] [Related]
40. Methamphetamine decreases calcium-calmodulin dependent protein kinase II activity in discrete rat brain regions.
Suemaru J; Akiyama K; Tanabe Y; Kuroda S
Synapse; 2000 Jun; 36(3):155-66. PubMed ID: 10819896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
